Clinical Research Directory
Browse clinical research sites, groups, and studies.
Personalisation of Mean Arterial Pressure in Adult Patients With Cardiogenic Shock
Sponsor: CMC Ambroise Paré
Summary
Cardiogenic shock is a life-threatening condition characterized by inadequate cardiac output, leading to organ hypoperfusion and high mortality. Maintaining mean arterial pressure (MAP) is crucial, but standard targets may be insufficient due to venous congestion. Central venous pressure (CVP) can help assess effective perfusion pressure. This study investigates whether a personalized MAP target adjusted by CVP improves organ function and survival compared to standard MAP management.
Official title: Prospective, Randomized, Multicenter, Controlled Trial Assessing the Personalization of Mean Arterial Pressure in Adult Patients With Cardiogenic Shock
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
406
Start Date
2026-03-26
Completion Date
2029-07-25
Last Updated
2026-04-02
Healthy Volunteers
No
Conditions
Interventions
Personalized MAP
Patients receive blood pressure management targeting a personalized MAP ranging from 65 mmHg + CVP to 75 mmHg + CVP, without exceeding 90 mmHg.CVP is measured via a central venous catheter positioned in the superior vena cava. After 48 hours, if tissue perfusion is restored, the MAP target may be reduced to 65-70 mmHg.
Standard MAP
Patients receive blood pressure management aiming for a standard MAP target of 65-70 mmHg, according to international guidelines for cardiogenic shock management.
Locations (11)
CHU d'Amiens-Picardie
Amiens, France
Hôpital Henri Mondor
Créteil, France
Hôpital Privé Jacques Cartier
Massy, France
CMC Ambroise Paré - Hartmann
Neuilly-sur-Seine, France
CHU d'Orléans
Orléans, France
Hôpital Lariboisière
Paris, France
Hôpital Cochin
Paris, France
Clinique NCT + /Saint-Gatien
Saint-Cyr-sur-Loire, France
Centre Cardiologique du Nord
Saint-Denis, France
CHRU de Strasbourg
Strasbourg, France
CHU de Toulouse
Toulouse, France